Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands.
Am Heart J. 2012 Jan;163(1):57-65.e2. doi: 10.1016/j.ahj.2011.09.002. Epub 2011 Nov 23.
In patients with ST-segment elevation myocardial infarction (STEMI), the importance of a well-balanced inflammatory reaction has been recognized for years. Monocytes play essential roles in regulating inflammation. Hence, we investigated the association between inflammatory characteristics of monocytes and myocardial injury and functional outcome in patients with STEMI.
Using flow cytometry, the levels of classical (CD14(++)CD62L(+)) and nonclassical (CD14(+)CD62L(-)) monocytes were analyzed in peripheral blood in 58 patients with STEMI at a median of 5 days (4-6 days) after primary percutaneous coronary intervention. In addition, the monocytic expression of several surface molecules and formation of monocyte-platelet complexes were measured. All patients underwent cardiovascular magnetic resonance imaging at baseline and 4-month follow-up.
At baseline, patients with high levels of classical monocytes had impaired left ventricular (LV) ejection fraction (P = .002), larger infarct size (P = .001), and, often, presence of microvascular obstruction (P = .003). At follow-up, high levels of classical monocytes were negatively associated with the regional systolic LV function independent of the transmural extent of infarction. In contrast, positive associations for the levels of nonclassical monocytes were observed. Finally, up-regulation of macrophage 1 by blood monocytes and increased formation of monocyte-platelet complexes were associated with enhanced myocardial injury at baseline and impaired LV function at follow-up.
This study shows an association between a proinflammatory monocyte response, characterized by high levels of classical monocytes, and severe myocardial injury and poor functional outcome after STEMI. Future studies are required to investigate the biologic nature of this association and therapeutic implications.
多年来,人们已经认识到 ST 段抬高型心肌梗死(STEMI)患者中炎症反应的重要性。单核细胞在调节炎症中起着至关重要的作用。因此,我们研究了单核细胞的炎症特征与 STEMI 患者心肌损伤和功能结局之间的关系。
使用流式细胞术,在首次经皮冠状动脉介入治疗后中位数为 5 天(4-6 天)时,分析了 58 例 STEMI 患者外周血中的经典(CD14(++)CD62L(+))和非经典(CD14(+)CD62L(-))单核细胞的水平。此外,还测量了单核细胞表面分子的表达和单核细胞-血小板复合物的形成。所有患者均在基线和 4 个月随访时进行心血管磁共振成像。
基线时,高水平经典单核细胞的患者左心室(LV)射血分数受损(P=0.002),梗死面积较大(P=0.001),且常有微血管阻塞(P=0.003)。在随访中,高水平经典单核细胞与区域收缩 LV 功能呈负相关,而与梗死的透壁程度无关。相比之下,高水平非经典单核细胞呈正相关。最后,血液单核细胞中巨噬细胞 1 的上调和单核细胞-血小板复合物的形成增加与基线时心肌损伤加重和随访时 LV 功能受损相关。
本研究表明,促炎单核细胞反应与严重的心肌损伤和 STEMI 后功能结局不良之间存在关联,其特征为高水平经典单核细胞。需要进一步研究来探讨这种关联的生物学性质和治疗意义。